LU90791I2 - Potentialisateur d'effets antineoplasique et agent antineoplasique - Google Patents

Potentialisateur d'effets antineoplasique et agent antineoplasique

Info

Publication number: LU90791I2
Authority: LU; Luxembourg
Prior art keywords: antineoplastic; potentiating; potentiator; agent; antineoplastic effect
Prior art date: 1990-09-07

Application number

LU90791C

Other languages

English (en)

Original Assignee

Taiho Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-07

Filing date

2001-08-06

Publication date

2001-10-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17034249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90791(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-08-06 Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd

2001-10-08 Publication of LU90791I2 publication Critical patent/LU90791I2/fr

Links

230000000118 anti-neoplastic effect Effects 0.000 title abstract 7
229940034982 antineoplastic agent Drugs 0.000 title abstract 4
239000002246 antineoplastic agent Substances 0.000 title abstract 4
230000003389 potentiating effect Effects 0.000 abstract 5
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 abstract 4
VVIAGPKUTFNRDU-UHFFFAOYSA-N 6S-folinic acid Natural products C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-UHFFFAOYSA-N 0.000 abstract 2
MPJKWIXIYCLVCU-UHFFFAOYSA-N Folinic acid Natural products NC1=NC2=C(N(C=O)C(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)CC(=O)O)CN2)C(=O)N1 MPJKWIXIYCLVCU-UHFFFAOYSA-N 0.000 abstract 2
VVIAGPKUTFNRDU-ABLWVSNPSA-N folinic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 VVIAGPKUTFNRDU-ABLWVSNPSA-N 0.000 abstract 2
235000008191 folinic acid Nutrition 0.000 abstract 2
239000011672 folinic acid Substances 0.000 abstract 2
229960001691 leucovorin Drugs 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
WFWLQNSHRPWKFK-ZCFIWIBFSA-N tegafur Chemical compound O=C1NC(=O)C(F)=CN1[C@@H]1OCCC1 WFWLQNSHRPWKFK-ZCFIWIBFSA-N 0.000 abstract 2
229960001674 tegafur Drugs 0.000 abstract 2
229940035893 uracil Drugs 0.000 abstract 2
241000124008 Mammalia Species 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Saccharide Compounds (AREA)
Compounds Of Unknown Constitution (AREA)

LU90791C 1990-09-07 2001-08-06 Potentialisateur d'effets antineoplasique et agent antineoplasique LU90791I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP23871990		1990-09-07
PCT/JP1991/001187 WO1992004028A1 (fr)	1990-09-07	1991-09-05	Potentialisateur d'effets antineoplasique et agent antineoplasique

Publications (1)

Publication Number	Publication Date
LU90791I2 true LU90791I2 (fr)	2001-10-08

Family

ID=17034249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU90791C LU90791I2 (fr)	1990-09-07	2001-08-06	Potentialisateur d'effets antineoplasique et agent antineoplasique

Country Status (14)

Country	Link
EP (1)	EP0500953B1 (fr)
JP (1)	JP2557303B2 (fr)
KR (1)	KR0146952B1 (fr)
AT (1)	ATE141506T1 (fr)
AU (1)	AU644684B2 (fr)
CA (1)	CA2071819A1 (fr)
DE (2)	DE10299023I2 (fr)
DK (1)	DK0500953T3 (fr)
ES (1)	ES2091941T3 (fr)
GR (1)	GR3021003T3 (fr)
HU (1)	HU211739A9 (fr)
LU (1)	LU90791I2 (fr)
NL (1)	NL300041I2 (fr)
WO (1)	WO1992004028A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH05310573A (ja) *	1992-05-01	1993-11-22	Dotsuto:Kk	リウマチ治療薬
US5643191A (en) *	1995-01-26	1997-07-01	Sorin Biomedical Inc.	Cardioplegia delivery system and method for converting from warm cardioplegia to cold cardioplegia
US5702358A (en) *	1995-02-23	1997-12-30	Sorin Biomedical Inc.	Cardioplegia delivery apparatus and method of use
US5660835A (en) *	1995-02-24	1997-08-26	East Carolina University	Method of treating adenosine depletion
RU2198171C2 (ru) *	1998-10-12	2003-02-10	Леонидов Николай Борисович	Новая кристаллическая модификация 5-фтор-1-(тетрагидро-2-фурил)-урацила и комплексные соединения на ее основе, обладающие противоопухолевым действием
JP4610481B2 (ja)	2003-03-14	2011-01-12	大鵬薬品工業株式会社	抗腫瘍効果増強剤及び抗腫瘍剤
TWI468188B (zh)	2008-01-30	2015-01-11	Univ Tokushima	Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
AU2008356312B2 (en)	2008-05-12	2015-04-09	Shizuoka Prefecture	Antitumor agent, kit, and method for treating cancer
KR102258514B1 (ko) *	2019-09-23	2021-05-31	연세대학교 산학협력단	신규한 다층형 좌약 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5953885B2 (ja) *	1978-02-10	1984-12-27	大鵬薬品工業株式会社	抗腫瘍剤組成物
GB2016921B (en) *	1978-03-27	1982-08-18	Taiho Pharmaceutical Co Ltd	Anti cancer compositions containing uracil derivatives
JPS5780319A (en) *	1980-11-06	1982-05-19	Taiho Yakuhin Kogyo Kk	Anti-tumor agent having reduced toxicity

1991
- 1991-09-05 DE DE10299023C patent/DE10299023I2/de active Active
- 1991-09-05 KR KR1019920701073A patent/KR0146952B1/ko not_active Expired - Lifetime
- 1991-09-05 DE DE69121551T patent/DE69121551T2/de not_active Expired - Lifetime
- 1991-09-05 AT AT91915614T patent/ATE141506T1/de active
- 1991-09-05 AU AU84479/91A patent/AU644684B2/en not_active Expired
- 1991-09-05 CA CA002071819A patent/CA2071819A1/fr not_active Abandoned
- 1991-09-05 WO PCT/JP1991/001187 patent/WO1992004028A1/fr not_active Ceased
- 1991-09-05 DK DK91915614.1T patent/DK0500953T3/da active
- 1991-09-05 ES ES91915614T patent/ES2091941T3/es not_active Expired - Lifetime
- 1991-09-05 JP JP3514805A patent/JP2557303B2/ja not_active Expired - Lifetime
- 1991-09-05 EP EP91915614A patent/EP0500953B1/fr not_active Expired - Lifetime
1995
- 1995-06-30 HU HU95P/P00730P patent/HU211739A9/hu unknown
1996
- 1996-09-12 GR GR960402353T patent/GR3021003T3/el unknown
2001
- 2001-03-21 NL NL300041C patent/NL300041I2/nl unknown
- 2001-08-06 LU LU90791C patent/LU90791I2/fr unknown

Also Published As

Publication number	Publication date
DE69121551D1 (de)	1996-09-26
NL300041I1 (nl)	2001-06-01
HU211739A9 (en)	1995-12-28
DE10299023I1 (de)	2003-06-05
DE69121551T2 (de)	1997-01-02
DE10299023I2 (de)	2010-05-06
NL300041I2 (nl)	2002-02-01
DK0500953T3 (da)	1997-01-06
JP2557303B2 (ja)	1996-11-27
WO1992004028A1 (fr)	1992-03-19
EP0500953B1 (fr)	1996-08-21
KR0146952B1 (ko)	1998-08-17
KR927002224A (ko)	1992-09-03
EP0500953A1 (fr)	1992-09-02
AU8447991A (en)	1992-03-30
ATE141506T1 (de)	1996-09-15
EP0500953A4 (en)	1993-04-21
ES2091941T3 (es)	1996-11-16
CA2071819A1 (fr)	1992-03-08
AU644684B2 (en)	1993-12-16
GR3021003T3 (en)	1996-12-31

Similar Documents

Publication	Publication Date	Title
NL970006I1 (nl)	1997-04-01	Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
SE8504967L (sv)	1986-04-24	Farmaceutisk komposition och forfarande for behandling av kroppen
FI935847A0 (fi)	1993-12-23	L-DOPA-esterkompositioner
ITMI912024A1 (it)	1993-01-22	Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
CA2039197A1 (fr)	1991-09-30	Formule pharmaceutique pour le traitement de l'alcoolisme
MY111260A (en)	1999-10-30	Pharmaceutical composition for the treatment of nicotine dependence
DE69105040D1 (de)	1994-12-15	Arzneimittel gegen Impotenz.
LU90791I2 (fr)	2001-10-08	Potentialisateur d'effets antineoplasique et agent antineoplasique
WO1990014831A3 (fr)	1991-01-24	Composition anti-virale de 3'-azido-2',3'-didesoxy-5-methylcytidine
IL97054A0 (en)	1992-03-29	Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
MY104521A (en)	1994-04-30	Treatment of depression.
ITRM920693A1 (it)	1994-03-24	Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hivsieropositivi.
NO810480L (no)	1981-08-14	Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
CA2038025A1 (fr)	1991-09-15	Derives de l'alkylenedioxybenzene optiquement actifs et leur utilisation a des fins therapeutiques
IL88222A0 (en)	1989-06-30	Medicaments comprising 2-pyrimidinyl-1-piperazine derivatives
FR2534809B1 (fr)	1985-06-28	Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
DE69233315D1 (de)	2004-04-08	Pharmazeutische lysin enthaltende polypeptid-zusammensetzungen und verfahren zu deren verwendung
DE3867251D1 (de)	1992-02-13	Medikamente fuer die behandlung von rheumatoider arthritis.
CY2337B1 (en)	2004-02-06	Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 invection.
ATE109003T1 (de)	1994-08-15	Therapeutisches mittel gegen pollakiurie, harndrang oder harninkontinenz, das alpha-phenyl- alpha-pyridylalkan-carbonsäurederivate enthält.
JPS6442434A (en)	1989-02-14	Gepilone for alleviating fright trouble
MY110416A (en)	1998-05-30	Composition for the treatment of schizophrenia.
CA2153570A1 (fr)	1994-08-04	Composition pharmaceutique permettant de traiter la dependance a la nicotine